Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography
Obstetrics & Gynecology Science · 2023-01-15 · 66 (1) · 1-10
DOI: 10.5468/ogs.22263 ↗At a glance
Journal article in Obstetrics & Gynecology Science, published on 2023-01-15. Written by Gwang Jun Kim and 2 co-authors. Institution: Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul, Korea. Cited 13 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
The two main screening tests during pregnancy are those for chromosomal abnormalities and neural tube defects (NTDs). In particular, for NTDs, measurement of maternal serum alpha-fetoprotein (MSAFP) levels early in the second trimester (15-18 weeks of gestation) has been considered the gold standard screening test for the past 4 decades. However, with remarkable technological advancements and the widespread use of ultrasound during those periods, mid-trimester ultrasonography has gradually replaced the role of measuring MSAFP levels as a screening method for NTDs. This change was initiated more about 10 years ago in some countries, which have issued national guidelines to use mid-trimester ultrasonography instead of measuring MSAFP levels as a prenatal screening method for NTDs. However, no significant changes have occurred in Korea, where second-trimester ultrasonography is routinely performed with high-quality equipment. We aimed to provide information regarding the importance of changing the screening method for NTDs from MSAFP measurement to ultrasonography, and to detail methods of implementing mid-trimester ultrasonography for screening purposes. We also share our experience of operating a prenatal diagnostic program for NTDs without using MSAFP for more than 15 years.
Subjects
Author keywords
Authors and institutions
- Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul, Korea.
- Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
Cite
APA
Kim, G. J., Seong, J. S., & Oh, J. A. (2023). Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography. Obstetrics & Gynecology Science, 66(1), 1-10. https://doi.org/10.5468/ogs.22263
Vancouver
Kim GJ, Seong JS, Oh JA. Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography. Obstetrics & Gynecology Science. 2023;66(1):1-10. doi:10.5468/ogs.22263
BibTeX
@article{Kim2023,
author = {Kim, Gwang Jun and Seong, Ji Su and Oh, Jin A},
title = {Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography},
journal = {Obstetrics & Gynecology Science},
year = {2023},
volume = {66},
number = {1},
pages = {1--10},
doi = {10.5468/ogs.22263}
}
EUVIMED